T2D Clinical Trial
Official title:
Effectivity and Safety of Autologous BM-MNC Stem Cell Therapy and Allogenic Umbilical Cord Mesenchymal Stem Cell for Type 2 Diabetes Mellitus Patients"
The aim of this preliminary study is to evaluate the safety and efficacy of bone-marrow mononuclear cells (BM-MNCs) and umbilical-cord tissue-derived mesenchymal stem cells (UC-MSCs) administration in type 2 diabetes patients
Type 2 diabetes (T2D) patients had peripheral insulin resistance accompanied by progressive pancreatic beta cell degeneration and dysfunction due to glucotoxicity and lipotoxicity. Several studies have shown that the immune system plays a significant role in the pathogenesis of T2D. Bone-marrow mononuclear cells (BM-MNCs) and umbilical-cord tissue-derived mesenchymal stem cells (UC-MSCs) via its immunomodulatory properties have the potential to improve insulin resistance condition and pancreatic beta-cells dysfunction thus improve the glycemic control and insulin requirement in T2D patients. In this pilot study, we plan to recruit 15 T2D patients with total daily dose of insulin >= 0.5 unit/kgBW/day to receive BM-MNCs (5 subjects) or UC-MSCs injections (10 subjects). These subjects will be closely followed up for 12 months for evaluation of primary and secondary outcome. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03194152 -
Peanut Consumption and Cardiovascular Disease Risk in a Chinese Population
|
N/A | |
| Enrolling by invitation |
NCT05760677 -
Study on the Efficacy and Safety of Chiglitazar Sodium in PCOS With T2DM
|
Phase 1 | |
| Not yet recruiting |
NCT05980754 -
Clinical Study on Exploring High Risk Factors Inducing the Progress of Diabetes
|
||
| Active, not recruiting |
NCT06445335 -
Prevalence of NAFLD in T2DM Patients
|
N/A | |
| Completed |
NCT03195400 -
Pathogenesis of Youth Onset Type 2 Diabetes and Prediabetes
|
||
| Active, not recruiting |
NCT05662332 -
A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time (QWINT-1)
|
Phase 3 | |
| Recruiting |
NCT05536804 -
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
|
Phase 2 | |
| Completed |
NCT04011904 -
The Role of Traditional or Western Diet in the TBC1D4 Gene on Glucose Homeostasis in Greenland Inuits
|
N/A | |
| Active, not recruiting |
NCT05260021 -
A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both
|
Phase 3 |